Lori Kunkel reports an option exercise at ELVN
By AlphaYouPublished Form 4
Kunkel Lori Anne
Reporting filer
Lori Anne Kunkel reports an option exercise, not an open-market purchase or sale, in Enliven Therapeutics, Inc.. Form 4 filed Nov 3, 2026 lists 4 entries.
- Disclosed
- Nov 3, 2026
Reported details
4 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Kunkel Lori Anne | 2026-10-30 | M | Exercise or conversion | 3741 | 1.12 | 45,625 | 4 days | Filed terms
|
| Common Stock | Kunkel Lori Anne | 2026-10-30 | M | Exercise or conversion | 7300 | 18.30 | 52,925 | 4 days | Filed terms
|
| Stock Option (right to buy) (derivative) | Kunkel Lori Anne | 2026-10-30 | M | Exercise or conversion | 3741 | 0 | 0 | 4 days | Filed terms
|
| Stock Option (right to buy) (derivative) | Kunkel Lori Anne | 2026-10-30 | M | Exercise or conversion | 7300 | 0 | 30,582 | 4 days | Filed terms
|
Common Stock
- Owner
- Kunkel Lori Anne
- Date
- 2026-10-30
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 3741
- Price
- 1.12
- Following holdings
- 45,625
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-30
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 3741
- transaction Price Per Share: 1.12
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 45625
- direct Or Indirect Ownership: D
- nature Of Ownership:
Common Stock
- Owner
- Kunkel Lori Anne
- Date
- 2026-10-30
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 7300
- Price
- 18.30
- Following holdings
- 52,925
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-30
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 7300
- transaction Price Per Share: 18.30
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 52925
- direct Or Indirect Ownership: D
- nature Of Ownership:
Stock Option (right to buy) (derivative)
- Owner
- Kunkel Lori Anne
- Date
- 2026-10-30
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 3741
- Price
- 0
- Following holdings
- 0
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 1.12
- transaction Date: 2026-10-30
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 3741
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F1
- expiration Date: 2030-06-15
- underlying Security Title: Common Stock
- underlying Security Shares: 3741
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
- nature Of Ownership:
Stock Option (right to buy) (derivative)
- Owner
- Kunkel Lori Anne
- Date
- 2026-10-30
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 7300
- Price
- 0
- Following holdings
- 30,582
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 18.30
- transaction Date: 2026-10-30
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 7300
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F2
- expiration Date: 2034-04-08
- underlying Security Title: Common Stock
- underlying Security Shares: 7300
- shares Owned Following Transaction: 30582
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Kunkel Lori Anne: Director.
- F1: All of the shares subject to this option are fully vested and exercisable as of the date hereof.
- F2: The option, originally for 37,882 shares, of which 7,300 shares have been exercised, vests as to 1/36th of the shares on May 8, 2024 and each month thereafter, subject to the Reporting Person continuing as an outside director through each such date.
Original sources
Prepared automatically from public filing data. Report a correction.